Adeia Inc. (ADEA): what the price requires
At today's price, Adeia Inc. (ADEA) is priced for today's economics sustained for ~6.2 years. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high.
Generated: 2026-07-19 · Source: https://boothcheck.com/report/ADEA
Headline
| Field | Value |
|---|---|
| Ticker | ADEA |
| Company | Adeia Inc. |
| Current price | $27.57/sh |
What The Price Requires (Inversion)
The assumption today's price embeds, recovered by inverting the valuation.
| Field | Value |
|---|---|
| Inversion basis | whole-company |
| Operating margin needed | 39.4% |
| Operating margin today | 27.7% |
| Margin expansion implied | +11.7pp |
| Must persist for | 6.2y |
| Multiple paid | 33x operating income |
The operating-margin requirement is derived from the framework's value band at year 12, a separately labeled basis from the headline growth/duration solve.
Solve inputs: computed at a 9% cost of capital; growth searched up to the 25% self-funding ceiling; each 1pp moves the implied horizon ~1.9 years.
How unusual the bet is: high
| Reference | Value |
|---|---|
| vs own history | +0.74σ |
| cohort percentile (of 33 peers) | 79 |
| sustained it ~6.2 years at this level | 25% |
| implied end-window share | 0% |
Valuation X-Ray
Asset, earnings-power and peer-multiple models all land far below the price; ONLY the growth-DCF reaches it. The bet is durable compounding the static frames structurally cannot price (a moat/durability premium).
How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.
| Family | Median price/FV | Models | Reads |
|---|---|---|---|
| Asset | 2.39x | 5 | expensive |
| Earnings | 2.36x | 5 | expensive |
| Relative | 1.69x | 5 | expensive |
| Growth | 0.71x | 3 | justifies |
Families that justify the price: Growth Families that call it expensive: Asset, Earnings, Relative
The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 8.3%); the inversion above states its own rate.
Per-Model Detail (n=18)
| Model | Family | FV | Price/FV | Applicable | Methodology |
|---|---|---|---|---|---|
| DCF Perpetual Growth | Growth | $50.13 | 0.55x | yes | FCF base $0.2B, growth 18% (input: historical growth), terminal g 4.0%, WACC 8.4%, 6yr projection |
| DCF Exit Multiple | Growth | $38.72 | 0.71x | yes | Exit EV/EBITDA: 16.8x / 18.8x / 20.8x (bear / base = today's held flat / bull), 6yr |
| Relative Valuation | Relative | $16.32 | 1.69x | yes | P/E 14.74x (blended: static sector reference 10x + trailing (TTM) 26x), scenarios: 12.1x / 14.7x / 17.4x (bear / base = reference held flat / bull), EV/EBITDA 10.53x |
| Simple DDM | Growth | — | — | no | — |
| Two-Stage DDM | Growth | — | — | no | — |
| Simple Excess Return | Asset | $11.55 | 2.39x | yes | BV/sh $4.09, ROE (TTM) 26.2%, ke 9.3% |
| Two-Stage Excess Return | Asset | $19.63 | 1.40x | yes | 5yr excess ROE then converge to ke=9.3% |
| Discounted Future Market Cap | Growth | $29.50 | 0.93x | yes | Rev $0.5B, growth 18% (input: historical growth; tapered), Terminal P/S: 5.6x / 6.8x / 8.1x (bear / base = today's held flat / bull, cap 12x) |
| Peter Lynch Fair Value | Relative | $38.15 | 0.72x | yes | EPS $1.09, growth 35% (input: historical EPS growth), PEG=0.74 (Undervalued) |
| Margin Trajectory | Growth | — | — | no | — |
| Earnings Power Value | Earnings | $6.98 | 3.95x | yes | Normalized EBIT (5y avg op income, one-time charges added back) $0.12B × (1−19%) / WACC 8.4% → EPV (no growth) |
| Residual Income | Asset | $17.22 | 1.60x | yes | BV $4.09 + 5yr PV of (ROE (TTM) 26.2% − Kₑ 9.3%) × BV; BV grows 8.8%/yr |
| Graham Number | Asset | $10.01 | 2.75x | yes | √(22.5 × EPS $1.09 × BVPS $4.09) — Graham's conservative floor |
| EV/EBITDA Relative | Relative | $8.27 | 3.33x | yes | EBITDA $0.19B × sector EV/EBITDA 7.0x |
| FCF Yield | Earnings | $11.68 | 2.36x | yes | FCF $157.4M / Kₑ 9.3% — zero-growth perpetuity |
| SBC-Adj FCF Yield | Earnings | $8.35 | 3.30x | yes | SBC-adj FCF $0.12B (FCF $0.16B − SBC $0.04B) capitalized at Kₑ |
| Ben Graham Formula | Earnings | $35.17 | 0.78x | yes | EPS $1.09 × (8.5 + 2×15.0%) × (4.4 / 5.3%) |
| ROIC-Justified P/B | Asset | $1.66 | 16.61x | yes | BV $4.09 × (ROIC 3.4% / WACC 8.4%) |
| P/Sales Sector | Relative | $4.84 | 5.70x | yes | Revenue $0.46B × sector P/S 1.2x |
| PEG Fair Value | Relative | $40.88 | 0.67x | yes | EPS $1.09 × (PEG 1.5 × growth 25.0% (input: historical EPS growth)) → PE 37.5x |
| Earnings Yield | Earnings | $11.78 | 2.34x | yes | EPS $1.09 / required return 9.3% (Rf 4.3% + ERP 5.0%) |
| Funds From Operations Multiple | Relative | — | — | no | — |
| Clinical Phase NPV | Growth | — | — | no | — |
| Merton | Asset | — | — | no | — |
| V5 Mechanical | — | — | — | no | — |
Solvency
| Field | Value |
|---|---|
| Net debt | $275.5m |
| Net debt / NOPAT (after-tax) | 3.35x |
| Net debt / operating income (pre-tax) | 2.73x |
| Interest coverage | 2.6x |
| Share count CAGR (dilution) | 2.0% |
| Burning cash | no |
Bullet Takeaways
- Adeia is an intellectual-property licensing company: it owns patents in media and semiconductors and collects royalties from companies that use the technology, a high-margin model running near a 40% operating margin with very little capital behind it.
- The defining feature lately is the shift away from its legacy Pay-TV base toward new verticals, with non-Pay-TV recurring revenue up about 30% year over year on fresh deals with the likes of AMD and Microsoft.
- The defining risk is renewal and enforcement: licenses can convert to "fully paid-up" when a term ends, which stops the royalty, and the company sometimes has to sue, as it recently did against Dish, to get paid at all.
Bull Case
The counterintuitive thing about Adeia is that a business everyone files under fading Pay-TV royalties is quietly winning its biggest new deals in semiconductors. The market remembers Adeia for licensing media and set-top technology, a category in secular decline as traditional television shrinks. But the recent deal flow runs the other way: multi-year agreements with AMD and Microsoft, eight to nine new or renewed licenses in a single quarter, and a roughly 30% year-over-year jump in non-Pay-TV recurring revenue. The hidden story is a portfolio pivoting from a declining vertical into growing ones, and the income statement has not yet been re-rated for it.
The economics of IP licensing are what make that pivot so valuable. Adeia describes a "long track record of innovating in the fields of media and semiconductors," and the model monetizes that innovation without manufacturing anything: it recognizes royalty revenue "based on the customer's sale or usage of the IP," so each new licensee adds high-margin, recurring revenue with almost no incremental cost. The result is a 40%-plus operating margin and a return on equity above 26% on a tiny book value, the signature of a business whose real asset, the patent portfolio, sits off the balance sheet. As the mix shifts toward semiconductors, where chip volumes are growing and the technology is increasingly central, the royalty base broadens onto a larger and more durable foundation.
The financial profile supports the re-rating thesis. Adeia generated free cash flow comfortably above net income, carries modest leverage at under 1.5 times operating income with interest covered nearly five times, and recently earned a credit-rating upgrade that lowers its cost of capital. It pays a small dividend and converts most of its cash into debt paydown and shareholder return. The bull case is a high-margin royalty machine that the market still prices as a melting Pay-TV ice cube, even as its newest and largest agreements are in the parts of technology that are growing, not shrinking.
Bear Case
Strip away the deal headlines and the bear case is about what the price is pricing: years of renewals and new licenses that are not yet signed. Adeia trades at about 38 times company-wide operating income, a multiple that implies operating profit compounding near its self-funding ceiling for roughly seven years, and the historical record shows only about 20% of comparable fast-growers sustained that kind of pace for that long. An IP licensor's revenue is inherently lumpy and term-limited, so paying a premium multiple is paying for a renewal cadence to continue indefinitely, which is exactly the assumption most likely to disappoint.
The structural fragility is built into how licensing works. Adeia warns that its agreements may convert "to fully paid-up licenses upon expiration of a specified term," after which it "may not receive further fees" from that customer. A paid-up conversion is a royalty stream simply ending, and because the portfolio's patents themselves expire over time, the company is on a treadmill: it must keep signing and renewing just to stand still. Enforcement is the other half of the problem. The filing is candid that absent litigation, "our customers and others may seek to use our technology and IP without a license or without the payment of license fees," which is why Adeia regularly ends up in court, most recently suing Dish. A business that depends on lawsuits to collect what it is owed carries a different risk profile than a subscription company with contractual recurring revenue.
The credit and concentration risks round it out. Adeia notes that some of its customers "may face severe financial difficulties from time to time, which may result in their inability to make payments," and licensing revenue is concentrated in a handful of large agreements, so the loss or non-renewal of one major licensee can swing a year. The static valuation methods see this clearly: the asset, earnings-power, and peer-multiple lenses all sit below the price, and only the forward-growth method reaches it. The bear case is not that Adeia is a bad business, the margins prove otherwise, but that the price already credits a smooth, multi-year renewal-and-expansion path for a model whose revenue is term-limited, litigation-dependent, and lumpy by nature.
Valuation
The price makes a demanding assumption for a business this lumpy. At $31.82 (June 27, 2026) Adeia trades at about 38 times company-wide operating income, which inverts to operating profit compounding near its self-funding ceiling for roughly seven years. The historical base rate is that only about 20% of comparable fast-growers sustained that pace that long, and for an IP licensor, whose revenue arrives in multi-year chunks that can convert to paid-up and stop, the persistence assumption is the entire bet.
The families of methods line up the way they do for a high-margin name priced on growth. The asset-value methods, anchored on a book value of only about $4.09 a share, land far below the price, but that lens is nearly meaningless here because the real asset is the patent portfolio, which is not on the balance sheet. The earnings-power and peer-multiple methods also sit below the price. The single family that reaches $31.82 is the forward-growth lens, which credits the recent licensing momentum and the shift into semiconductors. So the static methods uniformly say richly valued, and only growth justifies the price, the classic profile of a stock priced on a durable-compounding thesis the trailing numbers cannot yet confirm.
Solvency is solid and removes financial risk from the picture. Net debt of about $276 million is under 1.5 times operating income, interest is covered nearly five times, and a recent credit-rating upgrade lowers the cost of capital, the company is not burning cash and pays a small dividend while servicing its debt comfortably. The downside is therefore bounded not by liquidation value, which the asset methods put far below the price, but by the renewal cadence: the value rests on Adeia continuing to sign and renew high-value licenses faster than its existing ones expire or convert to paid-up. The decisive question is durability of the royalty stream, and that is precisely what a premium multiple on a term-limited, enforcement-dependent licensing model assumes will hold.
Catalysts
The deal flow is the catalyst that matters, and it has been strong. Adeia reported eight new and renewed license agreements in a recent quarter, including multi-year deals with AMD and Microsoft, nine total licensing deals, and a roughly 30% year-over-year increase in non-Pay-TV recurring revenue, the clearest evidence of its expansion into semiconductors and new media verticals. For 2026 the company reiterated revenue guidance of $395 million to $435 million. Because each major license can move a year, the cadence of new and renewed agreements is the single most important data point.
The enforcement track is its own catalyst, in both directions. Adeia's subsidiaries filed a patent-infringement lawsuit against Dish Network and certain affiliates in federal court in Colorado, the kind of action that can eventually convert an unlicensed user into a paying one but that also signals the litigation risk inherent in the model. Legal outcomes are binary and slow, so they sit in the background as potential step-changes rather than steady contributors.
Sentiment has improved alongside a credit upgrade. The covering analysts lean heavily Buy, with an average target above the current price and at least one firm raising its target into the low-to-mid $40s, and a recent S&P credit-rating upgrade reflects a stronger balance sheet and lower cost of capital. The variables to watch from here are the pace of semiconductor licensing wins, which carry the growth thesis, and any renewals coming due on legacy agreements, which carry the risk of paid-up conversions that quietly remove revenue.
Peer Cohorts (Per Segment, With Filing Citations)
IP Licensing (reported)
- RMBS (RAMBUS INC)
- FY2025 10-K: …from existing or potential customers, as any litigation opponents may attempt to use such proceedings to delay or otherwise impair any pending cases and our existing or potential customers may await the final outcome of any proceedings before agreeing to new licenses or to paying royalties. 30 Table of Contents…
- FY2025 10-K: …others may seek to use our technology without the payment of license fees and royalties, which could weaken our competitive position, reduce our operating results and increase the likelihood of costly litigation. The growth of our business depends in part on the use of our IP in the products of third parties and our…
- PSKY (Paramount Skydance Corporation)
- FY2025 10-K: …For affiliate revenues, payments are generally due monthly. Subscription revenues to our streaming services are recognized evenly over the subscription period. Theatrical Revenues -Theatrical revenue is earned from the theatrical distribution of our films during the exhibition period. Under these arrangements,…
- FY2025 10-K: …rating or impressions delivered to the total guaranteed in the contract. To the extent the amounts billed exceed the amount of revenue recognized, such excess is deferred until the guaranteed audience ratings or impressions are delivered. Affiliate Revenues -The performance obligation for our affiliate agreements is…
Methodology Note
- Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
- Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
- Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
- Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.
Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.
Sources
Adeia Q1 2026 results and commentary · company FY2026 guidance, 2026 · company announcement, 2026 · analyst actions and rating agency, 2026